Richmond Pharmacology and Trial4Us were referenced in a recent Guardian article titled: Clinical trials: how taking the pills may pay those bills.

The focus is on how clinical research organisations, such as Richmond Pharmacology, are encouraging volunteers to participate in crucial early phase clinical research and how their experience is tailored to ensure they are as comfortable as possible during the process. For example, providing access to super fast broadband to enable volunteers to continue to work from the unit, stream entertainment or access in-house entertainment such as Netflix, games and reading materials. We also have a concierge service to help with transport and accommodation options. The article also contains important safety and regulatory assurances for members of the public.

Richmond Pharmacology are sector leaders in the conduct of clinical trials in both healthy and patient populations. This is demonstrated though excellent feedback and high retention rates which are essential in the safe delivery of clinical studies.

Reflections from our recent trial participants are available to view here.

Latest news

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Patient with rare bleeding disorder becomes first to test new treatment

May 22, 2024
The thousands of patients who participate in Richmond’s trials are helping to advance medical science and save lives and, in the process, some make history. In a film released today, one trial participant tells her story.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event